Professor William Cushley

  • Assistant Vice-Principal International (External Relations)
  • Professor (Molecular Biosciences)

telephone: 01413305261
email: William.Cushley@glasgow.ac.uk

R315, Life Sciences Biomolecular Sci, Davidson Building, Glasgow G12 8QQ

Import to contacts

Research interests

Research groups

Publications

List by: Type | Date

Jump to: 2012 | 2010 | 2009 | 2008 | 2007 | 2005 | 2003 | 2002 | 2000
Number of items: 13.

2012

Edkins, A.L., Borland, G., Kelly, S.M. , Cogdell, R.J. , Ozanne, B.W. and Cushley, W. (2012) Analysis of the CD23-αv integrin interaction: a study with model peptides. Biochemical and Biophysical Research Communications, 422(2), pp. 207-212. (doi: 10.1016/j.bbrc.2012.04.076)

Edkins, A.L., Borland, G., Acharya, M., Cogdell, R.J. , Ozanne, B.W. and Cushley, W. (2012) Differential regulation of monocyte cytokine release by αv and β2 integrins that bind CD23. Immunology, 136(2), pp. 241-251. (doi: 10.1111/j.1365-2567.2012.03576.x)

2010

Acharya, M., Borland, G., Edkins, A.L., MacLellan, L.M., Matheson, J., Ozanne, B.W. and Cushley, W. (2010) CD23/FceRII: molecular multi-tasking. Clinical and Experimental Immunology, 162(1), pp. 12-23. (doi: 10.1111/j.1365-2249.2010.04210.x)

2009

Acharya, M., Edkins, A.L., Ozanne, B.W. and Cushley, W. (2009) SDF-1 and PDGF enhance [alpha]v[beta]5-mediated ERK activation and adhesion-independent growth of human pre-B cell lines. Leukemia, 23(10), pp. 1807-1817. (doi: 10.1038/leu.2009.126)

2008

Tsimbouri, P. , Al-Sheikh, Y., Drotar, M. E., Cushley, W. and Wilson, J.B. (2008) Epstein-Barr virus nuclear antigen-1 renders lymphocytes responsive to IL-2 but not IL-15 for survival. Journal of General Virology, 89(11), pp. 2821-2832. (doi: 10.1099/vir.0.83296-0)

2007

Borland, G., Edkins, A., Acharya, M., Matheson, J., White, L., Allen, J., Bonnefoy, J., Ozanne, B. and Cushley, W. (2007) alpha v beta 5 integrin sustains growth of human pre-B cells through an RGD-independent interaction with a basic domain of the CD23 protein. Journal of Biological Chemistry, 282, pp. 27315-27326. (doi: 10.1074/jbc.M609335200)

Borland, G., Edkins, A.L., Acharya, M., Matheson, J., White, L.J., Allen, J.M., Bonnefoy, J.-Y., Ozanne, B. W. and Cushley, W. (2007) vbeta5 Integrin Sustains Growth of Human Pre-B Cells through an RGD-independent Interaction with a Basic Domain of the CD23 Protein. Journal of Biological Chemistry, 282(37), pp. 27315-27326. (doi: 10.1074/jbc.M609335200)

2005

Cushley, W. (2005) Inflammation and immune diseases: What is at the summit? Drug Discovery Today, 10, pp. 752-754.

2003

Salehzadeh, A., Akhkha, A., Cushley, W., Adams, R., Kusel, J. and Strang, R. (2003) The antimitotic effect of the neem terpenoid azadirachtin on cultured insect cells. Insect Biochemistry and Molecular Biology, 33, pp. 681-689. (doi: 10.1016/S0965-1748(03)00057-2)

2002

Ewart, M., Ozanne, B. and Cushley, W. (2002) The CD23a and CD23b proximal promoters display different sensitivities to exogenous stimuli in B lymphocytes. Genes and Immunity, 3(3), pp. 158-164. (doi: 10.1038/sj/gene/6363848)

2000

O'Donnel, M.A., Cushley, W. and Wilson, J.B. (2000) Modulation of Immune Responses in Transgenic Mouse Models of EBV Lymphomagenesis. 9th Biennial Conference of the International Assoication for Research on Epstein-Barr Virus, New Haven, CT, USA, 22-27 Jun 2000.

Tsimbouri, P. , Cushley, W. and Wilson, J.B. (2000) EBNA1 Mechanism of Action as an Oncogene. 9th Biennial Conference of the International Assoication for Research on Epstein-Barr Virus, New Haven, CT, USA, 22-27 Jun 2000.

Tsimbouri, P. , Cushley, W. and Wilson, J.B. (2000) EBNA-1 Action as an Oncogene. 10th TENOVUS Scotland Symposium: Gene Expression and Disease, Glasgow, UK, 10-12 Apr 2000.

This list was generated on Sat Dec 21 12:43:18 2024 GMT.
Jump to: Articles | Conference or Workshop Item
Number of items: 13.

Articles

Edkins, A.L., Borland, G., Kelly, S.M. , Cogdell, R.J. , Ozanne, B.W. and Cushley, W. (2012) Analysis of the CD23-αv integrin interaction: a study with model peptides. Biochemical and Biophysical Research Communications, 422(2), pp. 207-212. (doi: 10.1016/j.bbrc.2012.04.076)

Edkins, A.L., Borland, G., Acharya, M., Cogdell, R.J. , Ozanne, B.W. and Cushley, W. (2012) Differential regulation of monocyte cytokine release by αv and β2 integrins that bind CD23. Immunology, 136(2), pp. 241-251. (doi: 10.1111/j.1365-2567.2012.03576.x)

Acharya, M., Borland, G., Edkins, A.L., MacLellan, L.M., Matheson, J., Ozanne, B.W. and Cushley, W. (2010) CD23/FceRII: molecular multi-tasking. Clinical and Experimental Immunology, 162(1), pp. 12-23. (doi: 10.1111/j.1365-2249.2010.04210.x)

Acharya, M., Edkins, A.L., Ozanne, B.W. and Cushley, W. (2009) SDF-1 and PDGF enhance [alpha]v[beta]5-mediated ERK activation and adhesion-independent growth of human pre-B cell lines. Leukemia, 23(10), pp. 1807-1817. (doi: 10.1038/leu.2009.126)

Tsimbouri, P. , Al-Sheikh, Y., Drotar, M. E., Cushley, W. and Wilson, J.B. (2008) Epstein-Barr virus nuclear antigen-1 renders lymphocytes responsive to IL-2 but not IL-15 for survival. Journal of General Virology, 89(11), pp. 2821-2832. (doi: 10.1099/vir.0.83296-0)

Borland, G., Edkins, A., Acharya, M., Matheson, J., White, L., Allen, J., Bonnefoy, J., Ozanne, B. and Cushley, W. (2007) alpha v beta 5 integrin sustains growth of human pre-B cells through an RGD-independent interaction with a basic domain of the CD23 protein. Journal of Biological Chemistry, 282, pp. 27315-27326. (doi: 10.1074/jbc.M609335200)

Borland, G., Edkins, A.L., Acharya, M., Matheson, J., White, L.J., Allen, J.M., Bonnefoy, J.-Y., Ozanne, B. W. and Cushley, W. (2007) vbeta5 Integrin Sustains Growth of Human Pre-B Cells through an RGD-independent Interaction with a Basic Domain of the CD23 Protein. Journal of Biological Chemistry, 282(37), pp. 27315-27326. (doi: 10.1074/jbc.M609335200)

Cushley, W. (2005) Inflammation and immune diseases: What is at the summit? Drug Discovery Today, 10, pp. 752-754.

Salehzadeh, A., Akhkha, A., Cushley, W., Adams, R., Kusel, J. and Strang, R. (2003) The antimitotic effect of the neem terpenoid azadirachtin on cultured insect cells. Insect Biochemistry and Molecular Biology, 33, pp. 681-689. (doi: 10.1016/S0965-1748(03)00057-2)

Ewart, M., Ozanne, B. and Cushley, W. (2002) The CD23a and CD23b proximal promoters display different sensitivities to exogenous stimuli in B lymphocytes. Genes and Immunity, 3(3), pp. 158-164. (doi: 10.1038/sj/gene/6363848)

Conference or Workshop Item

O'Donnel, M.A., Cushley, W. and Wilson, J.B. (2000) Modulation of Immune Responses in Transgenic Mouse Models of EBV Lymphomagenesis. 9th Biennial Conference of the International Assoication for Research on Epstein-Barr Virus, New Haven, CT, USA, 22-27 Jun 2000.

Tsimbouri, P. , Cushley, W. and Wilson, J.B. (2000) EBNA1 Mechanism of Action as an Oncogene. 9th Biennial Conference of the International Assoication for Research on Epstein-Barr Virus, New Haven, CT, USA, 22-27 Jun 2000.

Tsimbouri, P. , Cushley, W. and Wilson, J.B. (2000) EBNA-1 Action as an Oncogene. 10th TENOVUS Scotland Symposium: Gene Expression and Disease, Glasgow, UK, 10-12 Apr 2000.

This list was generated on Sat Dec 21 12:43:18 2024 GMT.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Development of pilot for national, population-based chronic non-communicable disease registers/surveillance system strengthening in the UK Overseas Territories
    Office for Health Improvement and Disparities
    2022 - 2024
     
  • avb5 integrin-co-receptor interactions controlling ALL growth and survival
    Blood Cancer UK
    2012 - 2014
     
  • Regulation of Pre-B ALL Cell Growth by Adhesion-Independent Signalling via the avb5 Integrin
    Leukaemia Research Fund
    2008 - 2010
     

Additional information

Editorial Board

  • 1998 - present: Immunology
  • 1988 - present: Biochemical Journal - Member, Editorial Advisory Board

Grant Advisory Board

  • 2006 - 2009: Medical Research Scotland - Member of the Grant Panel and Trustee
  • 2005 - present: Babraham Institute - Member of Audit Committee
  • 2004 - present: Babraham Institute - Member of the Board of Directors
  • 2003: European Commission Framework VI - Member, Evaluation Panel, Areas 41 and 42; The Environment & Health and Allergic Responses to Environmental Agents.
  • 2001: BBSRC - Member, Visiting Group, Babraham Institute
  • 2001 - 2005: BBSRC - Member, Experimental Research in Ageing (ERA) Initiative Working Party. Deputy Chairman of grants-awarding panel.
  • 2001: European Commission Framework V - Evaluator, Quality of Life Key Action 4; The Environment and Health. Evaluator, Quality of Life Special Call; Endocrine Disruptors. Evaluator and Member, Stage 2 Evaluation Panel, Quality of Life Key Action 7.3; Chronic & Degenerative Diseases.
  • 2001: BBSRC - Member, Molecular Sciences, Quality of Science Panel
  • 1998 - 2001: BBSRC - Member Science of Ageing (SAGE) Initiative Working Party.

Invited International Presentations

  • 2005: London, England - UK CLL Forum, invited speaker.
  • 2005: Philadelphia, USA - Inflamation and Immune Diseases, Strategic Research Institute, invited plenary speaker.

Professional Learned Society

  • - present: British Society of Immunology - Vice-Chair